3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Completed
4
Terminated
2
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumors
1
Sarcoma
1
Liposarcoma
1
Histiocytoma, Malignant Fibrous
1
Dermatofibrosarcoma
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
118
pembrolizumab
104
Specimen Handling
104
Magnetic Resonance Spectroscopy
94
fludarabine
92
Biopsy
77
Injections
53
Nivolumab
43
Bevacizumab
41
Fluorouracil
38
venetoclax
37
Cisplatin
36
Paclitaxel
35
Carboplatin
35
Cetuximab
34
Radiotherapy
31
Oxaliplatin
30
fludarabine phosphate
29
Leucovorin
28
Gemcitabine
28
Drug Therapy
25
Ipilimumab
23
Immunotherapy, Adoptive
23
Azacitidine
23
Radiation
21
Irinotecan
21
Temozolomide
20
Doxorubicin
20
tislelizumab
19
atezolizumab
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Recruiting
×
Famotidine
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled